Stay updated on Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial

Sign up to get notified when there's something new on the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page footer's revision tag was updated to v3.5.5, replacing the previous v3.5.4; this reflects a software/patch update rather than a change to study information.
    Difference
    0.1%
    Check dated 2026-06-05T12:18:37.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision label is updated to v3.5.4, indicating a minor update to the document version.
    Difference
    0.1%
    Check dated 2026-05-15T06:54:59.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page’s footer revision/version was updated from **v3.5.2** to **v3.5.3**, indicating a site release rather than a change to the clinical trial study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:54:23.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.2; the previous revision was v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:13:06.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:08:49.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T23:52:50.000Z thumbnail image

Stay in the know with updates to Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page.